The wait times in our emergency departments are longer than usual due to illnesses like RSV and the flu. View our estimated ED wait times and learn more about where to get care for your sick child.

Children’s Minnesota cystic fibrosis program honored by Cystic Fibrosis Foundation

Children’s Minnesota is pleased to announce that our cystic fibrosis (CF) program has been selected for the Cystic Fibrosis Foundation’s Quality Improvement Award.

The recognition celebrates programs that actively use clinical data to identify opportunities for improvement, consistently involve patients and families in designing these improvements, and employ innovative strategies to improve care. Our cystic fibrosis program was selected for its dedicated multidisciplinary care team, comprehensive trainee education, exceptional patient and family involvement, and communication tools that overcome barriers to care.

CF is a genetic condition that causes cells to produce mucus that is thicker and stickier, resulting in blocked ducts, which affects many systems in the body – from lungs and sinuses to sweat glands and the digestive system.

The cystic fibrosis program at Children’s Minnesota is led by Dr. Brooke Moore, chief of staff and pediatric pulmonologist, and includes a range of professionals, such as physicians, nurses, dietitians, respiratory therapists, physical therapists, genetic counselors, social workers and research coordinators. The program cares for approximately 150 kids per year.

A group photo of our cystic fibrosis team.

“Congratulations to the cystic fibrosis program on this well-deserved recognition. Their dedication to finding new treatments and bringing these innovations to the bedside to improve kids’ quality of life is remarkable,” said Dr. Emily Chapman, chief medical officer and senior vice president of medical affairs at Children’s Minnesota. “From diagnosing and testing to treating and managing the challenges of living with CF, they deliver on our vision of being every family’s essential partner in raising healthier children.”

The CF program is accredited by the Cystic Fibrosis Foundation, meaning it offers the best care, treatment and support for children with the condition. Children’s Minnesota is also a designated Therapeutics Development Network center. This connects us with top cystic fibrosis centers around the world that are actively researching new treatments and gives our patients access to a wide range of clinical trials.

More press releases and awards

Children’s Minnesota announces retirement of President and CEO Dr. Marc Gorelick
After a 42-year medical career and more than seven years leading Children’s Minnesota, Dr. Marc Gorelick, president and CEO of Children's Minnesota, announced his retirement effective July 2025....
Dr. Yoav Messinger honored with Charles Bolles Bolles-Rogers Award
Congratulations to Yoav Messinger, MD, pediatric oncologist at Children’s Minnesota, for being honored with the Charles Bolles Bolles-Rogers Award. The award is presented by the Advocates for Better Health Foundation...
Children’s Minnesota awards Community Health Innovation Fund grants
Children’s Minnesota’s Collective for Community Health announces the first recipients of its Community Health Innovation Fund grants in partnership with Delta Dental....